Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Topical NGF demonstrates efficacy in the treatment of corneal ulcers

May 21, 1998

Alcon's diclofenac sodium approved for ocular inflammation indication

May 20, 1998

Another market introduction for Xalatan

May 18, 1998

Verteporfin proven safe in phase III trials

May 15, 1998

Vitrase shown to clear vitreous hemorrhage

May 15, 1998

Akorn launches generic cromolyn sodium

May 12, 1998

VISX Excimer Laser System approved in Japan

May 11, 1998

Novo Nordisk discovers potent sst4 receptor agonist

May 5, 1998

First market introduction for Alcon's newest ophthalmic drug

May 5, 1998

Update on Repligen's angiogenesis inhibitors

May 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...